Valsartan products cannot be used in Malaysia
KUALA LUMPUR, July 7 (Bernama) -- 'Valsartan' products which were reportedly withdrawn from the market in the United Kingdom should not be in the Malaysian market.
Health Department director-general-cum-Drug Control Authority (DCA) chairman Datuk Dr Noor Hisham Abdullah said checks with the registration list of National Pharmacy Regulatory Division (NPRA) found that the products from the product registration holders were not registered with the DCA.
"These products should not be in the market and cannot be used in this country," he said in a statement today.
It was reported that the recall followed an urgent investigation into medicines containing valsartan used to treat high blood pressure and heart conditions.
-- BERNAMA
HealthEdge
EXCLUSIVE
Pet Vaccination, Public Awareness And Surveillance Key Towards Rabies-free Southeast Asia - Experts
KUCHING, Dec 11 (Bernama) -- The goal of making Southeast Asia free from human rabies can be achieved through a total understanding of the disease, how it can be prevented and responsible pet ownership among communities, say experts.
read more ››IN FOCUS
APA ITU MELODY TPV?
Pandangan rakyat Malaysia tentang peningkatan sasaran pemberian vaksin COVID-19 kepada 70 peratus.
UMSC: Pain Management
In Focus : UMSC Raya Open House 2018
In Focus: UMSC Consultant Speaks Erectile Dysfunction Precursor For Heart Disease Part 2